Prognostic factors in prostatic leiomyosarcoma: a pooled analysis of 143 reported cases

Area of Science:

• Oncology
• Urologic Pathology
• Cancer Epidemiology

Background:

• Prostatic leiomyosarcoma is a rare and aggressive malignancy.
• Limited prognostic data exists for this condition.
• A pooled analysis of 143 cases was conducted to identify prognostic markers.

Purpose of the Study:

• To identify key prognostic markers for prostatic leiomyosarcoma.
• To analyze survival outcomes based on various clinical and pathological factors.
• To determine predictors of mortality in patients with prostatic leiomyosarcoma.

Main Methods:

• Pooled analysis of 143 cases from 82 published reports.
• Kaplan-Meier survival analysis.
• Multivariate Cox and logistic regression analyses.
• Chi-square/Fisher's exact tests for associations.

Main Results:

• Median overall survival was 25 months.
• Metastasis (13 vs 32 months, P=.04), mixed histology (5 vs 27 months, P=.04), positive surgical margins (15 vs 29 months, P=.02), and elevated PSA (>4 ng/mL) (3 vs 27 months, P=.04) were associated with reduced survival.
• Metastasis (HR=3.66, P=.02) and tumor recurrence (OR=3.41, P=.01) were significant predictors of mortality.
• Spindle cell morphology was associated with metastatic risk (P=.04).

Conclusions:

• Metastasis and tumor recurrence are key predictors of mortality in prostatic leiomyosarcoma.
• Early identification and management of metastasis and recurrence are crucial for improving patient outcomes.
• Further research is warranted to develop targeted therapies for this rare malignancy.